Localized hyperthermia induction via alternating magnetic field

Localized hyperthermia induction via alternating magnetic field is not a molecular target but rather a therapeutic approach. It involves the use of magnetic nanoparticles that are delivered to specific sites—typically tumors—and then exposed to an externally applied alternating magnetic field. This exposure causes the nanoparticles to generate heat locally through mechanisms such as Néel and Brownian relaxation losses. The resulting increase in temperature can selectively kill cancer cells while sparing surrounding healthy tissue if carefully controlled. The effectiveness depends on factors like nanoparticle size, concentration, composition, and the parameters of the applied magnetic field. This method is under investigation primarily for cancer therapy but is limited by challenges such as ensuring precise localization of heat and avoiding systemic toxicity from the particles themselves. There are no drugs that directly interact with this "target," nor does it have canonical molecular biomarkers—it is best described as a physical/technological intervention rather than a biological target.

Other names

Magnetic hyperthermiaMagnetic nanoparticle hyperthermiaAlternating magnetic field-induced hyperthermiaAMF-induced local heating

Heat generation by magnetic nanoparticles exposed to an alternating magnetic field causes localized temperature increases that can induce cell death in targeted tissues